News & Analysis on Clinical Trial Services & Contract Research And Development
By Melissa Fassbender
- Last updated on
David B. Fleishman became BBK Worldwide’s newest Principal in April. A company veteran, Fleishman will be taking on new responsibilities, including directing site services as well as helping set the strategic direction for BBK’s continued growth.
“As the newest BBK Worldwide principal, I am eager to help define strategic direction and drive continued growth for the company, while helping the industry to overcome enrollment challenges to bring new treatments to the patients that need them,” said Fleishman.
“I am also excited to be taking on the role of director of site services where I look to impact the training and support of site study staff in the effort to enhance the clinical trial experience.”